Assignee
HDL THERAPEUTICS INC
US·5 granted patents·10 pending applications·8 citations·filing 2018–2024
Top patents by PatentIndex Score
15 records- 0186US11400188B2Systems for removing air from the fluid circuits of a plasma processing systemHDL THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·2 cites·20 claims
- 0286US11033582B1Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradationHDL THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·2 cites·14 claims
- 0383US10821133B2Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasmaHDL THERAPEUTICS INC·Filed 2018·Granted Nov 3, 2020·2 cites·16 claims
- 0477US2024148786A1Methods for Preserving and Administering Pre-Beta High Density Lipoprotein Having a Predetermined Minimum Level of DegradationHDL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0573US11027052B2Systems and methods for priming fluid circuits of a plasma processing systemHDL THERAPEUTICS INC·Filed 2018·Granted Jun 8, 2021·2 cites·19 claims
- 0669US11903965B2Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradationHDL THERAPEUTICS INC·Filed 2021·Granted Feb 20, 2024·0 cites·14 claims
- 0769US2018355021A1Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid ContentHDL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0860US2023355180A1Methods for Treating Cholesterol-Related DiseasesHDL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0955US2023140014A1Methods and Systems for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer’s Disease, and/or Acute StrokeHDL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1053US2022202857A1Systems and methods for reducing low attenuation plaque and/or plaque burden in patientsHDL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1149US2021283201A1Systems and Methods for Treating Patients Infected with SARS-COV-2HDL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1247US2019381070A1Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and/or Acute StrokeHDL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1344US2019021674A1Methods for Treating Cholesterol-Related DiseasesHDL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1441US2020171086A1Methods for Treating Lipid-Related Diseases Including Xanthomas, Carotid Artery Stenoses, and Cerebral AtherosclerosisHDL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1538US2019070257A1Methods for Prophylactically Preventing, Slowing the Progression of, or Treating Alzheimer's DiseaseHDL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HDL THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →